Viking Therapeuticsadmin2022-01-17T17:31:32+00:00 Project Description Initial Public Offering Common Stock $27,600,000 Sole Book-Runner May 2015 Related Project Details Categories: IPO Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInTumblrPinterestVkEmail Related Projects